Delivery Order SPE2DB20D2104-SPE2DB26FMBFM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $2,206.28. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, issued on a non-set-aside basis through competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Naloxone HCL 4 mg nasal spray in a quantity of 2 units. This contract is valued at $1,135.68 with a firm fixed price structure and an ultimate completion date of September 2, 2025. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $1,993.25 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-pack units). This contract is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,640.38 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's critical role as a pharmaceutical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,507.14 for Naloxone HCL 4 mg nasal spray on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,728.00 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on May 6, 2025, with completion due by May 7, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,033.92 firm fixed price delivery order for Naloxone HCL 4 mg nasal spray on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitive award, which carries no set-aside designation, represents a child contract action under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's headquarters location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,591.90 to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray on July 16, 2025, with an ultimate completion date of July 17, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,189.90 for Naloxone HCl 4 mg nasal spray on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order is not set-aside and will be performed in Conshohocken, Pennsylvania, where the awardee maintains its corporate headquarters. The product represents critical medical supply for overdose reversal, which supports the agency's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,470.53 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBFMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,237.02 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-spray units). This is a firm fixed-price, non-set-aside contract with a completion date of October 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal healthcare systems, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare programs. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to fulfill diverse medical commodity needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/29/25 |